de Oliveira, Fábio Morato https://orcid.org/0000-0003-4167-627X
Jamur, Valderez Ravaglio
Merfort, Lismeri Wuicik
Pozzo, Aline Rangel
Mai, Sabine
Article History
Received: 27 October 2021
Accepted: 14 September 2022
First Online: 29 September 2022
Declarations
:
: Informed written consent was obtained from all the patients in accordance with the declaration of Helsinki. The patients whose samples were used in this study were selected from the Hematology Service of the Clinical Hospital of the Federal University of Paraná, Curitiba, Brazil. This study was received and approved by the Research Ethics Committee of the Federal University of Paraná, Curitiba, Brazil (CAE: 87629318.3.0000.0096).
: Not applicable.
: S.M. is a shareholder, director, and chair of the clinical and scientific advisory board of Telo Genomics Corp. (Toronto, ON, Canada). The other authors declare that they have no conflicts of interest.